Mankind Pharma is set to acquire Panacea Biotec Pharma’s formulations for an estimated Rs 1872 crores.... Mar 02
DengiAll has been found to be safe and well-tolerated with no serious adverse effects ... Sep 24
Panacea Biotec and Refana are targeting to manufacture 500 million COVID-19 vaccines over 12 months... Jun 11
Panacea Biotec receives USD 24.32 Million Award of Pentavalent Vaccine from U.N. Agencies ... Jan 01
-Advertisements-